Mark Ratain

NPI: 1255494779
Total Payments
$25,478
2024 Payments
$11,050
Companies
5
Transactions
6
Medicare Patients
176
Medicare Billing
$26,988

Payment Breakdown by Category

Consulting$25,450 (99.9%)
Food & Beverage$28.24 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $25,450 5 99.9%
Food and Beverage $28.24 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim RCV GmbH & Co KG $11,050 1 $0 (2024)
EMD Serono, Inc. $8,225 1 $0 (2021)
APTEVO THERAPEUTICS INC $5,200 2 $0 (2020)
Shionogi Inc $975.00 1 $0 (2017)
AstraZeneca Pharmaceuticals LP $28.24 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $11,050 1 Boehringer Ingelheim RCV GmbH & Co KG ($11,050)
2021 $8,225 1 EMD Serono, Inc. ($8,225)
2020 $2,275 1 APTEVO THERAPEUTICS INC ($2,275)
2018 $2,925 1 APTEVO THERAPEUTICS INC ($2,925)
2017 $1,003 2 Shionogi Inc ($975.00)

All Payment Transactions

6 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
01/11/2024 Boehringer Ingelheim RCV GmbH & Co KG Consulting Fee Cash or cash equivalent $11,050.00 General
06/12/2021 EMD Serono, Inc. Consulting Fee Cash or cash equivalent $8,225.00 General
10/23/2020 APTEVO THERAPEUTICS INC Consulting Fee Cash or cash equivalent $2,275.00 General
08/24/2018 APTEVO THERAPEUTICS INC Consulting Fee Cash or cash equivalent $2,925.00 General
10/27/2017 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $28.24 General
07/18/2017 Shionogi Inc Consulting Fee Cash or cash equivalent $975.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 31 31 $27,909 $3,671
2022 2 26 26 $23,783 $3,679
2021 4 77 108 $54,510 $11,475
2020 2 42 71 $38,433 $8,163
Total Patients
176
Total Services
236
Medicare Billing
$26,988
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 19 19 $15,807 $2,077 13.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 12 12 $12,102 $1,593 13.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 14 14 $13,847 $2,318 16.7%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 12 12 $9,936 $1,360 13.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 36 38 $33,560 $6,541 19.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 14 34 $8,914 $2,107 23.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 13 22 $8,368 $1,957 23.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 14 14 $3,668 $869.82 23.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 26 26 $21,993 $4,133 18.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 16 45 $16,440 $4,029 24.5%

About Mark Ratain

Mark Ratain is a Hematology & Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255494779.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Ratain has received a total of $25,478 in payments from pharmaceutical and medical device companies, with $11,050 received in 2024. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($25,450).

As a Medicare-enrolled provider, Ratain has provided services to 176 Medicare beneficiaries, totaling 236 services with total Medicare billing of $26,988. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Chicago, IL
  • Active Since 12/18/2006
  • Last Updated 10/24/2022
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1255494779

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Chicago